{"slideshow_credits": null, "snippet": "The drug is the second one brought to market by Vertex and could be effective for more patients than the first drug, Kalydeco.", "abstract": "Food and Drug Administration approves Orkambi, new cystic fibrosis treatment developed by Vertex Pharmaceuticals; approval is expected to make Vertex consistently profitable for the first time. ", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/07/03/business/orkambi-a-new-cystic-fibrosis-drug-wins-fda-approval.html", "lead_paragraph": "The drug is the second one brought to market by Vertex and could be effective for more patients than the first drug, Kalydeco.", "headline": {"main": "Orkambi, a New Cystic Fibrosis Drug, Wins F.D.A. Approval", "print_headline": "F.D.A. Approves New Drug for the Treatment of Cystic Fibrosis"}, "_id": "55957b6c38f0d82a206e5079", "word_count": "410", "multimedia": [], "pub_date": "2015-07-03T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Vertex Pharmaceuticals Inc", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Cystic Fibrosis", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}